GLAS was appointed as Facility Agent and Security Trustee in connection with TPG's majority investment in iNova Pharmaceuticals, a leading independent consumer healthcare & medicine products company in Asia Pacific, alongside co-investors.

After a 2020 restructure under a Scheme of Arrangement, Codere undertook further restructuring in 2021 involving bridge notes financing, new money injection, and a debt-for-equity swap to transfer business to Codere New Topco SA. In 2021, we effected a Luxembourg share pledge enforcement.